Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Van Helden

Showing results (31-40 of 383) with videos related to

Pageof 39
Sort By:
Personalized Medicine|May 24, 2018
NAT2 polymorphisms and their influence on the pharmacology and toxicity of isoniazid in TB patientsCedric J Werely, Peter R Donald, Paul D van Helden
Plos One|August 23, 2007
A threshold value for the time delay to TB diagnosisPieter W Uys, Robin M Warren, Paul D van Helden
The Onderstepoort Journal of Veterinary Research|February 5, 2016
The prevalence of antibodies to Toxoplasma gondii in sheep in the Western Cape, South AfricaKenneth Hammond-Aryee, Lesley S Van Helden, Paul D Van Helden
Transboundary and Emerging Diseases|November 1, 2013
Mycobacteria and disease in southern AfricaL Botha, N C Gey van Pittius, P D van Helden
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|August 1, 1993
Laboratory experience and guidelines for avoiding false positive polymerase chain reaction resultsT Victor, A Jordaan, R du Toit, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 19, 2010
Measuring minimum inhibitory concentrations in mycobacteriaFrederick A Sirgel, Ian J F Wiid, Paul D van Helden
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 1994
The detection of Mycobacterium tuberculosis in bone marrow aspirate using the polymerase chain reactionE H Lombard, T Victor, A Jordaan, et al.
Journal of Clinical Microbiology|February 10, 2004
IS6110-mediated deletion polymorphism in isogenic strains of Mycobacterium tuberculosisS L Sampson, M Richardson, P D Van Helden, et al.
Human Genetics|February 9, 2007
SP110 polymorphisms are not associated with pulmonary tuberculosis in a South African populationC Babb, E Hanekom Keet, P D van Helden, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 19, 2010
Insertion element IS6110-based restriction fragment length polymorphism genotyping of Mycobacterium tuberculosisRobin M Warren, Paul D van Helden, Nicolaas C Gey van Pittius
Pageof 39

Showing results (31-40 of 383) with videos related to

Sort By:
Pageof 39
Personalized Medicine|May 24, 2018
NAT2 polymorphisms and their influence on the pharmacology and toxicity of isoniazid in TB patientsCedric J Werely, Peter R Donald, Paul D van Helden
Plos One|August 23, 2007
A threshold value for the time delay to TB diagnosisPieter W Uys, Robin M Warren, Paul D van Helden
The Onderstepoort Journal of Veterinary Research|February 5, 2016
The prevalence of antibodies to Toxoplasma gondii in sheep in the Western Cape, South AfricaKenneth Hammond-Aryee, Lesley S Van Helden, Paul D Van Helden
Transboundary and Emerging Diseases|November 1, 2013
Mycobacteria and disease in southern AfricaL Botha, N C Gey van Pittius, P D van Helden
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|August 1, 1993
Laboratory experience and guidelines for avoiding false positive polymerase chain reaction resultsT Victor, A Jordaan, R du Toit, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 19, 2010
Measuring minimum inhibitory concentrations in mycobacteriaFrederick A Sirgel, Ian J F Wiid, Paul D van Helden
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 1994
The detection of Mycobacterium tuberculosis in bone marrow aspirate using the polymerase chain reactionE H Lombard, T Victor, A Jordaan, et al.
Journal of Clinical Microbiology|February 10, 2004
IS6110-mediated deletion polymorphism in isogenic strains of Mycobacterium tuberculosisS L Sampson, M Richardson, P D Van Helden, et al.
Human Genetics|February 9, 2007
SP110 polymorphisms are not associated with pulmonary tuberculosis in a South African populationC Babb, E Hanekom Keet, P D van Helden, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 19, 2010
Insertion element IS6110-based restriction fragment length polymorphism genotyping of Mycobacterium tuberculosisRobin M Warren, Paul D van Helden, Nicolaas C Gey van Pittius
Pageof 39